Safety of Growth Hormone Treatment in Patients Previously Treated for Cancer

ChemaitillyW.; RobisonL.L.

首页> 外文期刊>Endocrinology and Metabolism Clinics of North America >Safety of Growth Hormone Treatment in Patients Previously Treated for Cancer

【24h】

Safety of Growth Hormone Treatment in Patients Previously Treated for Cancer

机译：生长激素治疗在先前接受过癌症治疗的患者中的安全性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

This review provides an overview of the safety of growth hormone replacement therapy in individuals previously treated for cancer. The review focuses on the risk of disease recurrence and second neoplasm occurrence with special attention to data on childhood cancer survivors.

机译：这篇综述概述了生长激素替代疗法在先前接受过癌症治疗的个体中的安全性。这篇综述着重于疾病复发和第二肿瘤发生的风险，并特别关注有关儿童癌症幸存者的数据。

著录项

来源
《Endocrinology and Metabolism Clinics of North America》 |2012年第4期|共8页
作者
ChemaitillyW.; RobisonL.L.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词
Cancer recurrence; Cancer survivors; Childhood cancer survivor; Growth hormone deficiency; Second neoplasms;

机译：癌症复发;癌症幸存者;儿童癌症幸存者;生长激素缺乏症;第二肿瘤;

相似文献

外文文献
中文文献
专利

1. Safety of Growth Hormone Treatment in Patients Previously Treated for Cancer [J] . ChemaitillyW., RobisonL.L. Endocrinology and Metabolism Clinics of North America . 2012,第4期

机译：生长激素治疗在先前接受过癌症治疗的患者中的安全性
2. 385 A phase II trial to assess the efficacy and safety of gefitinib (Iressa?) in patients with metastatic hormone refractory prostate cancer (HRPC) who progressed on treatment with a luteinising hormone releasing hormone analogue (or post orchiectomy) plus an antiandrogen [J] . G.Curigliano, O.De Cobelli, M.T.Sandri, European Journal of Cancer Supplements . 2004,第8期

机译：385一项II期临床试验，评估吉非替尼（Iressa？）在使用黄体激素释放激素类似物（或睾丸切除术后）加抗雄激素治疗的转移性激素难治性前列腺癌（HRPC）患者中的疗效和安全性
3. TREATMENT WITH RECOMBINANT METHIONYL GROWTH HORMONE OF HYPOPITUITARY PATIENTS PREVIOUSLY TREATED WITH PITUITARY GROWTH HOROMONE [J] . H Hrisch, T Vilim, E Schober, Pediatric Research . 1988,第1期

机译：预先用垂体生长激素治疗的垂体病患者的重组甲硫基生长激素治疗
4. Results of treatment of patients with stomach cancer advanced form treated by combination of lw level laser therapy (LLLT) and other methods (10-years experience) [C] . V.A.Mikhailov Conference on Laser Florence'99: A Window on the Laser Medicine World 28-31 October 1999 Florence, Italy . 1999

机译：低水平激光疗法（LLLT）和其他方法相结合治疗晚期胃癌患者的结果（10年经验）
5. Treatment Interruption and Discontinuation of Hormone Therapy in Hormone Receptor-Positive Breast Cancer Patients [D] . Mao, Daqin . 2020

机译：激素受体阳性乳腺癌患者中的治疗中断与激素治疗中的中断和停止
6. Combined Evaluation of IGF−1 and IGFBP−3 as an Index of Efficacy and Safety in Growth Hormone Treated Patients [O] . Zeynep Şıklar, Gönül Öcal, Merih Berberoğlu, 2009

机译：IGF-1和IGFBP-3的综合评估作为生长激素治疗患者的疗效和安全性指标
7. Combined Evaluation of IGF−1 and IGFBP−3 as an Index of Efficacy and Safety in Growth Hormone Treated Patients [O] . Şıklar, Zeynep, Öcal, Gönül, Berberoğlu, Merih, 2009

机译：IGF-1和IGFBP-3的综合评估作为生长激素治疗患者的疗效和安全性指标

Safety of Growth Hormone Treatment in Patients Previously Treated for Cancer

摘要

著录项

相似文献

相关主题

期刊订阅